Cargando…
COVID-19 and Panax ginseng: Targeting platelet aggregation, thrombosis and the coagulation pathway
Coronavirus disease 2019 (COVID-19) not only targets the respiratory system but also triggers a cytokine storm and a series of complications, such as gastrointestinal problems, acute kidney injury, and myocardial ischemia. The use of natural products has been utilized to ease the symptoms of COVID-1...
Autores principales: | Lee, Yuan Yee, Quah, Yixian, Shin, Jung-Hae, Kwon, Hyuk-Woo, Lee, Dong-Ha, Han, Jee Eun, Park, Jin-Kyu, Kim, Sung Dae, Kwak, Dongmi, Park, Seung-Chun, Rhee, Man Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767971/ https://www.ncbi.nlm.nih.gov/pubmed/35068944 http://dx.doi.org/10.1016/j.jgr.2022.01.002 |
Ejemplares similares
-
Panax ginseng: Inflammation, platelet aggregation, thrombus formation, and atherosclerosis crosstalk
por: Lee, Yuan Yee, et al.
Publicado: (2022) -
In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism
por: Quah, Yixian, et al.
Publicado: (2023) -
The anti-platelet activity of panaxadiol fraction and panaxatriol fraction of Korean Red Ginseng in vitro and ex vivo
por: Lee, Yuan Yee, et al.
Publicado: (2023) -
Chemical diversity of ginseng saponins from Panax ginseng()
por: Shin, Byong-Kyu, et al.
Publicado: (2015) -
Ginseng Genome Database: an open-access platform for genomics of Panax ginseng
por: Jayakodi, Murukarthick, et al.
Publicado: (2018)